With the growing demand for generic medicines and biologics, pharmaceutical companies have identified the potential profitability in contracting with a contract manufacturing organization (CMO) for both clinical and commercial stage manufacturing. By partnering with the right CM, a medical device manufacturer can save plenty of time and overhead costs. The increased demand for capable and dependable CMOs has seen the global CMO market growing at an unprecedented rate. Another reason for this growth is the unexpected hit of the COVID-19 pandemic. To look for a cure, pharma giants are leaving no stones unturned to find a cure to this highly contagious virus. Other factors driving the growth of CMOs in the pharmaceutical industry is the growing need for state-ofthe- art processes and production technologies, which have proven highly effective in meeting regulatory requirements. CMOs are consolidating as a means of improving profitability in the competitive market. They are looking at new technologies to boost economies of scale, improve manufacturing productivity, and overall efficiency. To expand their capabilities and global market reach, these companies are entering into new alliances through mergers and acquisitions. Further, the relationship of pharmaceutical manufacturers with CMO and contract development and manufacturing organizations (CDMOs) is increasingly evolving from one-dimensional product outsourcing into a broad partnership model involving several aspects of development, testing, production and research.Although smaller firms have equal dependence as large drug companies on their CMO/CDMO partners, their priority is focused on a different set of solution offerings.While pharma companies refocus their core strengths and assets, CDMOs are playing a crucial role in providing added facilities to mitigate the risk of supply shortages by supplying multisite strategies and backup capacities. With CMOs entering the APAC market with their competitive solutions, companies need help to identify the right CMO partner. To help companies choose the right CMO solution partners best suited for them, Pharma Tech Outlook has compiled a list of top 10 CMOs in APAC. These companies are transforming the pharma landscape with various disruptive technologies and best in class solutions. We bring you PharmaTech Outlook’s “Top 10 CMOs in APAC - 2021.”
THANK YOU FOR SUBSCRIBING




![Bora Pharmaceuticals [TWO: 6472] - Top CMOs in APAC Bora Pharmaceuticals [TWO: 6472]](/company_logos/l2i8i22272.jpg)









